
Efficacy and Safety of Biologics Targeting Type 2 Inflammation in COPD: A Systematic Review and Network Meta-Analysis
Introduction Chronic obstructive pulmonary disease (COPD) is recognized by the World Health Organization (WHO) as the third leading cause of global mortality, imposing substantial health and socioeconomic burdens worldwide. Currently, it is believed that …